Compounds > paclitaxel
Page last updated: 2024-08-23

paclitaxel and Genetic Predisposition

paclitaxel has been researched along with Genetic Predisposition in 37 studies

Research

Studies (37)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (27.03)29.6817
2010's26 (70.27)24.3611
2020's1 (2.70)2.80

Authors

AuthorsStudies
Allan, A; Andrés, V; Andrés-Manzano, MJ; Blanco, Y; da Rocha, AM; Díaz-Larrosa, JJ; Fanjul, V; Filgueiras-Rama, D; González-Gómez, C; Gonzalo, P; Jalife, J; Macías, Á; Ponce-Balbuena, D1
Dai, CL; Dai, SB; Han, GH; Huang, JX; Lu, KJ; Zhang, LX1
Azoulay, D; Leibovici, A; Sharon, R1
Akiyoshi, K; Arai, M; Fujita, Y; Hayashi, H; Koh, Y; Kurata, T; Matsubara, N; Matsumoto, K; Minami, H; Mukai, H; Nakagawa, K; Nishio, K; Ohashi, Y; Ono, A; Onoe, T; Onozawa, Y; Sakai, K; Takeda, K; Takeuchi, A; Takiguchi, Y; Toyoda, M1
Albain, KS; Baltay, M; Barry, WT; Burstein, HJ; Carey, LA; Dang, CT; Dillon, DA; Ellis, MJ; Fuhrman, K; Guo, H; Hudis, CA; Krop, IE; Marcom, PK; Moy, B; Overmoyer, B; Partridge, AH; Pernas, S; Ritterhouse, L; Rugo, HS; Schneider, BP; Shapira, I; Shen, F; Tolaney, SM; Winer, EP; Wolff, AC; Yardley, DA1
Benedetti Panici, P; Boccia, SM; Di Donato, V; Di Mauro, F; Giancotti, A; Musacchio, L; Muzii, L; Palaia, I; Perniola, G; Tomao, F1
Camps, J; Dalton, S; Li, Y; Lyon, K; Ried, T; Tang, J; Zhao, S1
Avall-Lundqvist, E; González-Neira, A; Gréen, H; Hjerpe, E; Inglada-Pérez, L; Jara, C; Leandro-García, LJ; Leskelä, S; Mielgo, X; Pita, G; Robledo, M; Rodríguez-Antona, C1
Ben-Ami, S; Friedman, E; Har-Zahav, G; Kaufman, B; Laitman, Y; Pud, D; Rubinek, T; Symon, Z; Wolf, I; Yeheskel, A1
Carey, LA; Clark, LS; Dees, EC; Drobish, A; Hertz, DL; Jack, J; McLeod, HL; Motsinger-Reif, AA; Roy, S1
Chang, MC; Chen, CA; Cheng, WF; Chiang, YC; Hsieh, CY; Kuo, KT; Lin, HP; Lu, TP1
Grzybowska, E; Kolosza, Z; Pamula-Pilat, J; Radlak, N; Tecza, K1
Banck, MS; Behrens, RJ; Beutler, AS; Beyerlein, P; Boora, GK; Kanwar, R; Kulkarni, AA; Loprinzi, CL; Lynch, CA; Pleticha, J; Qin, R; Ruddy, KJ; Züchner, S1
Kaklamani, V; Siziopikou, K; Uthe, R; Waisbren, J1
Azoulay, D; Braester, A; Goldberg, H; Gross, B; Leibovici, A; Shaoul, E; Sharoni, R1
Kanazawa, S; Kaneko, H; Kikuchi, Y; Kobayashi, M; Kubota, Y; Magoshi, S; Murakami, Y; Natori, K; Ogata, H; Osaku, T; Saito, F; Shiraga, N1
Abyzov, A; Banck, MS; Beutler, AS; Boora, GK; Kanwar, R; Kulkarni, AA; Loprinzi, CL; Ruddy, KJ; Sloan, J1
Cho, KJ; Choi, C; Choi, JH; Choi, YJ; Gee, HY; Kim, SW; Kim, TH; Kwon, EY; Noh, SH; Park, HJ1
Foroud, T; Gardner, L; Jiang, G; Lai, D; Li, L; Miller, KD; O'Neill, A; Radovich, M; Schneider, BP; Shen, F; Sledge, GW; Sparano, JA; Xue, G1
Chen, X; Huang, B; Shang, C; Sun, L; Xu, H; Zhang, J; Zhao, B1
Erl, A; Hoppmann, P; Kastrati, A; Koch, W; Mehilli, J; Schömig, A; Tiroch, K; Türk, S1
Amant, F; Berteloot, P; Cadron, I; Legius, E; Leunen, K; Neven, P; Van Gorp, T; Vergote, I1
Jensen, S; Krarup-Hansen, A; Pedersen, JV; Riis, L1
Baricordi, OR; Ferlini, A; Indelli, M; Lelli, G; Rimessi, P; Rizzo, R; Spaggiari, F1
Haraguchi, Y; Hariki, H; Hirata, K; Honjo, T; Inoue, T; Ishida, T; Kawamori, H; Kozuki, A; Nishio, R; Sawada, T; Shinke, T; Shinohara, M; Shite, J; Toh, R1
Álvarez, S; Cascón, A; Comino-Méndez, I; de Cubas, AA; Gómez-Graña, Á; Inglada-Pérez, L; Landa, I; Leandro-García, LJ; Leskelä, S; Letón, R; Lozano, ML; Maliszewska, A; Martínez, C; Ramírez, JC; Rivera, J; Robledo, M; Rodríguez-Antona, C; Torres, R1
Baldwin, RM; Chhibber, A; Eclov, RJ; Friedman, PN; Hudis, CA; Jiang, C; Jorgenson, EM; Kroetz, DL; Kubo, M; McLeod, HL; Mefford, J; Nakamura, Y; Owzar, K; Ratain, MJ; Shulman, LN; Watson, D; Winer, EP; Witte, JS; Zembutsu, H1
Bergmann, TK; Brosen, K; Eckhoff, L; Feddersen, S; Gréen, H; Herrstedt, J; Vach, W1
Chen, XJ; Cheng, X; He, J; Li, QX; Shao, ZM; Shi, TY; Sun, MH; Wang, MY; Wei, Q; Wu, X; Yu, KD; Zhou, XY; Zhu, ML1
Culver, DG; Davis, AA; Glass, JD; Wang, MS1
Kruczek, A; Markowska, J; Skasko, E; Steffen, J; Wojciechowska-Lacka, A1
Afonso, N; Afonso-Lopes, C; Costa, S; Faleiro, C; Freitas-Silva, M; Lopes, C; Medeiros, R; Osório, T; Palmeira, C; Pereira, D; Vasconcelos, A1
Fujiwara, Y; Hasegawa, S; Miyoshi, Y; Monden, M; Noguchi, S; Takiguchi, S; Urano, N; Yano, M; Yasuda, T1
Ahrendt, SA; Chen, Y; Okunieff, P1
Araújo, AP; Catarino, R; Lopes, C; Medeiros, R; Pereira, D; Pinto, D; Portela, C; Rodrigues, C; Santos, AM; Sousa, H1
de Vries, ST; Fokkert, MJ; Maas, AH; Nadal, F; Niella, M; Slingerland, RJ; van 't Hof, AW; van Enst, GC1
Foretová, L; Fridrichová, P; Lukesová, S; Melichar, B; Mergancová, J; Ryska, A; Urminská, H1

Reviews

3 review(s) available for paclitaxel and Genetic Predisposition

ArticleYear
Liver Metastasis of a Triple-Negative Breast Cancer and Complete Remission for 5 Years After Treatment With Combined Bevacizumab/Paclitaxel/Carboplatin: Case Report and Review of the Literature.
    Medicine, 2015, Volume: 94, Issue:42

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; BRCA2 Protein; Carboplatin; Female; Genetic Predisposition to Disease; Germ-Line Mutation; Humans; Liver Neoplasms; Paclitaxel; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Remission Induction; Triple Negative Breast Neoplasms

2015
Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance).
    Cancer medicine, 2016, Volume: 5, Issue:4

    Topics: Alleles; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Multidrug Resistance-Associated Protein 2; Neoplasms; Odds Ratio; Paclitaxel; Peripheral Nervous System Diseases; Polymorphism, Single Nucleotide

2016
Translational research in lung cancer.
    Seminars in surgical oncology, 2003, Volume: 21, Issue:3

    Topics: Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cytokines; Genetic Predisposition to Disease; Genetic Testing; Humans; Lung Neoplasms; Paclitaxel; Prognosis; Radiation Pneumonitis

2003

Trials

4 trial(s) available for paclitaxel and Genetic Predisposition

ArticleYear
Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 03-01, Volume: 37, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Carboplatin; Female; Gene Expression Profiling; Genetic Predisposition to Disease; Humans; Japan; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Patient Selection; Phenotype; Precision Medicine; Predictive Value of Tests; Progression-Free Survival; Prospective Studies; Time Factors; Transcriptome

2019
Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 08-01, Volume: 37, Issue:22

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Breast Neoplasms, Male; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Genotype; Humans; Lymph Nodes; Male; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Poisson Distribution; Polymorphism, Single Nucleotide; Receptor, ErbB-2; Recurrence; Risk; Trastuzumab; Treatment Outcome

2019
Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans.
    Oncotarget, 2016, Dec-13, Volume: 7, Issue:50

    Topics: Antineoplastic Agents, Phytogenic; Black or African American; Breast Neoplasms; Chemotherapy, Adjuvant; Exome Sequencing; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Paclitaxel; Peripheral Nervous System Diseases; Phenotype; Polymorphism, Single Nucleotide; Protein Tyrosine Phosphatases, Non-Receptor; Risk Factors

2016
A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Sep-15, Volume: 18, Issue:18

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Female; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Humans; Incidence; Microfilament Proteins; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Polymorphism, Single Nucleotide; Receptor, EphA5; Sensory Receptor Cells

2012

Other Studies

30 other study(ies) available for paclitaxel and Genetic Predisposition

ArticleYear
Paclitaxel mitigates structural alterations and cardiac conduction system defects in a mouse model of Hutchinson-Gilford progeria syndrome.
    Cardiovascular research, 2022, 01-29, Volume: 118, Issue:2

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cytoskeleton; Disease Models, Animal; Excitation Contraction Coupling; Female; Genetic Predisposition to Disease; Heart Conduction System; Heart Rate; Lamin Type A; Male; Mice, Mutant Strains; Mutation; Myocytes, Cardiac; Paclitaxel; Progeria; Refractory Period, Electrophysiological; Swine; Swine, Miniature; Tubulin

2022
Association of serum annexin A1 with treatment response and prognosis in patients with esophageal squamous cell carcinoma.
    Journal of cancer research and therapeutics, 2018, Volume: 14, Issue:Supplement

    Topics: Adult; Aged; Annexin A1; Carcinoma, Squamous Cell; Cell Movement; Cell Proliferation; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Gene Expression Regulation, Neoplastic; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; MicroRNAs; Middle Aged; Paclitaxel; Prognosis

2018
BDNF Val66Met is Associated with Pre-existing but not with Paclitaxel-induced Peripheral Neuropathy in an Israeli Cohort of Breast Cancer Patients.
    The Israel Medical Association journal : IMAJ, 2018, Volume: 20, Issue:12

    Topics: Aged; Antineoplastic Agents, Phytogenic; Brain-Derived Neurotrophic Factor; Breast Neoplasms; Breast Neoplasms, Male; Cohort Studies; Female; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Israel; Male; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Polymerase Chain Reaction; Polymorphism, Single Nucleotide

2018
Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients?
    Gynecologic oncology, 2019, Volume: 154, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; BRCA2 Protein; Carboplatin; Cohort Studies; Cystadenocarcinoma, Serous; Female; Genes, BRCA1; Genes, BRCA2; Genetic Predisposition to Disease; Germ-Line Mutation; Hematologic Diseases; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Retrospective Studies

2019
Cancer driver-passenger distinction via sporadic human and dog cancer comparison: a proof-of-principle study with colorectal cancer.
    Oncogene, 2014, Feb-13, Volume: 33, Issue:7

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Cell Polarity; Cell Proliferation; Colorectal Neoplasms; Dogs; Genes, Tumor Suppressor; Genetic Predisposition to Disease; Genome-Wide Association Study; Guanine Nucleotide Exchange Factors; HCT116 Cells; Humans; Molecular Sequence Annotation; Paclitaxel; Pilot Projects; rab GTP-Binding Proteins; Receptors, Cytoplasmic and Nuclear

2014
Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy.
    Journal of medical genetics, 2013, Volume: 50, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Polymorphism, Single Nucleotide; Receptors, Eph Family

2013
Association between variants of 5-hydroxytryptamine receptor 3C (HTR3C) and chemotherapy-induced symptoms in women receiving adjuvant treatment for breast cancer.
    Breast cancer research and treatment, 2014, Volume: 144, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Paclitaxel; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Receptors, Serotonin, 5-HT3; Young Adult

2014
Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy.
    Breast cancer research and treatment, 2014, Volume: 145, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Cytochrome P-450 CYP2C8; Drug Resistance, Neoplasm; Female; Genetic Heterogeneity; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Oligonucleotide Array Sequence Analysis; Paclitaxel; Peripheral Nervous System Diseases; Polymorphism, Single Nucleotide; Young Adult

2014
Establishment of a New Ovarian Cancer Cell Line CA5171.
    Reproductive sciences (Thousand Oaks, Calif.), 2015, Volume: 22, Issue:6

    Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Cisplatin; Class I Phosphatidylinositol 3-Kinases; DNA Copy Number Variations; Doxorubicin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Humans; Middle Aged; Mutation; Neoplasm Invasiveness; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Phenotype; Phosphatidylinositol 3-Kinases; Polymorphism, Single Nucleotide; PTEN Phosphohydrolase; Tumor Suppressor Protein p53

2015
Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy.
    Journal of experimental & clinical cancer research : CR, 2015, Jan-16, Volume: 34

    Topics: Adolescent; Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Case-Control Studies; Cisplatin; Female; Gene Dosage; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Mortality; Neoplasm Grading; Ovarian Neoplasms; Paclitaxel; Polymorphism, Genetic; Young Adult

2015
Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance).
    Journal of the neurological sciences, 2015, Oct-15, Volume: 357, Issue:1-2

    Topics: Antineoplastic Agents, Phytogenic; Case-Control Studies; Charcot-Marie-Tooth Disease; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Models, Genetic; Mutation; Paclitaxel; Peripheral Nervous System Diseases; Pharmacogenetics; Polymorphism, Single Nucleotide; Rho Guanine Nucleotide Exchange Factors

2015
BRCA 1/2 gene mutation and gastrointestinal stromal tumours: a potential association.
    BMJ case reports, 2015, Jul-06, Volume: 2015

    Topics: Aged; Antineoplastic Agents, Alkylating; Breast Neoplasms, Male; Cyclophosphamide; Doxorubicin; Fatal Outcome; Gastrointestinal Stromal Tumors; Genes, BRCA2; Genetic Predisposition to Disease; Genotype; Germ-Line Mutation; Humans; Male; Mutation; Neoadjuvant Therapy; Paclitaxel; Predictive Value of Tests; Prostatic Neoplasms

2015
Association between Met-BDNF allele and vulnerability to paclitaxel-induced peripheral neuropathy.
    Breast cancer research and treatment, 2015, Volume: 153, Issue:3

    Topics: Alleles; Antineoplastic Agents, Phytogenic; Brain-Derived Neurotrophic Factor; Breast Neoplasms; Female; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Paclitaxel; Peripheral Nervous System Diseases

2015
Functional characterization of ABCB4 mutations found in progressive familial intrahepatic cholestasis type 3.
    Scientific reports, 2016, 06-03, Volume: 6

    Topics: ATP Binding Cassette Transporter, Subfamily B; Cholestasis, Intrahepatic; Cyclosporine; Gene Expression; Genetic Association Studies; Genetic Predisposition to Disease; HEK293 Cells; Humans; Kinetics; Leupeptins; Macrolides; Mutation, Missense; Paclitaxel; Protein Transport

2016
Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance.
    Oncotarget, 2017, Feb-28, Volume: 8, Issue:9

    Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Silencing; Genetic Predisposition to Disease; Humans; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA, Long Noncoding; Stomach Neoplasms

2017
No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drug-eluting stents.
    JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:11

    Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chromosomes, Human, Pair 9; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Phenotype; Polymorphism, Single Nucleotide; Proportional Hazards Models; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome

2009
Does paclitaxel-carboplatin chemotherapy in a dose-dense regimen enhance survival of BRCA-related ovarian cancer patients?
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2009, Volume: 19, Issue:9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Carboplatin; Carcinoma; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Female; Genetic Predisposition to Disease; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Survival Analysis; Treatment Outcome

2009
Scleroderma induced by paclitaxel.
    Acta oncologica (Stockholm, Sweden), 2010, Volume: 49, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Female; Genetic Predisposition to Disease; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Scleroderma, Localized; Sex Factors; Time Factors

2010
Association of CYP1B1 with hypersensitivity induced by taxane therapy in breast cancer patients.
    Breast cancer research and treatment, 2010, Volume: 124, Issue:2

    Topics: Aged; Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Breast Neoplasms, Male; Chemotherapy, Adjuvant; Chi-Square Distribution; Cytochrome P-450 CYP1B1; Cytochrome P-450 CYP2C8; Cytochrome P-450 Enzyme System; Docetaxel; Drug Hypersensitivity; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Italy; Logistic Models; Male; Middle Aged; Neoadjuvant Therapy; Odds Ratio; Paclitaxel; Phenotype; Polymorphism, Single Nucleotide; Retrospective Studies; Risk Assessment; Risk Factors; Taxoids; Treatment Outcome

2010
Impact of cytochrome P450 2C19*2 polymorphism on intra-stent thrombus after drug-eluting stent implantation in Japanese patients receiving clopidogrel.
    Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:1

    Topics: Aged; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Asian People; Cardiovascular Agents; Chi-Square Distribution; Cineangiography; Clopidogrel; Cytochrome P-450 CYP2C19; Drug-Eluting Stents; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Japan; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Phenotype; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Ticlopidine; Time Factors; Tomography, Optical Coherence; Treatment Outcome

2011
Hematologic β-tubulin VI isoform exhibits genetic variability that influences paclitaxel toxicity.
    Cancer research, 2012, Sep-15, Volume: 72, Issue:18

    Topics: Antineoplastic Agents; Genetic Predisposition to Disease; Genotype; Humans; Microtubules; Paclitaxel; Polymorphism, Single Nucleotide; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; Thrombocytopenia; Tubulin

2012
GWAS-based association between RWDD3 and TECTA variants and paclitaxel induced neuropathy could not be confirmed in Scandinavian ovarian cancer patients.
    Acta oncologica (Stockholm, Sweden), 2013, Volume: 52, Issue:4

    Topics: Antineoplastic Agents, Phytogenic; Carcinoma; Extracellular Matrix Proteins; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; GPI-Linked Proteins; Humans; Nervous System Diseases; Ovarian Neoplasms; Paclitaxel; Polymorphism, Single Nucleotide; Reproducibility of Results; Retrospective Studies; Scandinavian and Nordic Countries; Validation Studies as Topic

2013
Functional variants in TNFAIP8 associated with cervical cancer susceptibility and clinical outcomes.
    Carcinogenesis, 2013, Volume: 34, Issue:4

    Topics: 3' Untranslated Regions; Apoptosis Regulatory Proteins; Case-Control Studies; Cell Line, Tumor; China; Cisplatin; Drug Resistance, Neoplasm; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; MicroRNAs; Organoplatinum Compounds; Paclitaxel; Polymorphism, Single Nucleotide; Risk; Uterine Cervical Neoplasms

2013
WldS mice are resistant to paclitaxel (taxol) neuropathy.
    Annals of neurology, 2002, Volume: 52, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Axons; Cells, Cultured; Female; Ganglia, Spinal; Genetic Predisposition to Disease; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neurons, Afferent; Paclitaxel; Peripheral Nervous System Diseases; Phenotype; Wallerian Degeneration

2002
Frequent disease progression and early recurrence in patients with familial ovarian cancer primarily treated with paclitaxel and cis- or carboplatin (preliminary report).
    European journal of gynaecological oncology, 2003, Volume: 24, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Disease Progression; Female; Follow-Up Studies; Genes, BRCA1; Genetic Predisposition to Disease; Humans; Incidence; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Poland; Prospective Studies; Risk Factors; Sampling Studies; Survival Analysis; Treatment Failure

2003
Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome.
    International journal of clinical oncology, 2003, Volume: 8, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy, Needle; Cisplatin; Female; Genetic Predisposition to Disease; Glutathione Transferase; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Polymerase Chain Reaction; Polymorphism, Genetic; Predictive Value of Tests; Probability; Prognosis; Prospective Studies; Survival Analysis; Treatment Outcome

2003
Absence of beta-tubulin gene mutation in gastric carcinoma.
    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2003, Volume: 6, Issue:2

    Topics: Aged; Antineoplastic Agents, Phytogenic; Base Sequence; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cell Division; Codon; Drug Resistance, Neoplasm; Exons; Female; Genetic Predisposition to Disease; Humans; Introns; Japan; Lung Neoplasms; Male; Microtubules; Middle Aged; Mutation; Paclitaxel; Polymerase Chain Reaction; Predictive Value of Tests; Sequence Analysis, DNA; Stomach Neoplasms; Taxoids; Tubulin

2003
TP53 and P21 polymorphisms: response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer.
    Biochemical and biophysical research communications, 2006, Feb-03, Volume: 340, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Genetic Testing; Humans; Incidence; Middle Aged; Ovarian Neoplasms; Paclitaxel; Polymorphism, Genetic; Portugal; Prognosis; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Treatment Outcome; Tumor Suppressor Protein p53

2006
A case of very late stent thrombosis at high altitude.
    Thrombosis and haemostasis, 2007, Volume: 98, Issue:6

    Topics: Adult; Altitude; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Contraceptives, Oral; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Dehydration; Drug-Eluting Stents; Exercise; Female; Genetic Predisposition to Disease; Humans; Hypoxia; Myocardial Infarction; Paclitaxel; Risk Factors; Time Factors; Treatment Outcome

2007
Pathological complete response after primary chemotherapy in a mother and daughter with hereditary breast carcinoma: two case reports.
    European journal of gynaecological oncology, 2008, Volume: 29, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cyclophosphamide; Doxorubicin; Exons; Female; Gene Deletion; Genetic Predisposition to Disease; Humans; Mothers; Mutation; Nuclear Family; Paclitaxel; Ubiquitin-Protein Ligases

2008